Fig. 1 · Structure
Documents & Downloads
BDM31827
EthR Inhibitor
BDM31827 is an EthR inhibitor that targets the EthR protein to modulate drug resistance mechanisms in Mycobacterium tuberculosis. This compound demonstrates potential in overcoming multidrug-resistant tuberculosis by enhancing the efficacy of existing antimicrobial therapies. BDM31827 is a valuable tool for researching antibiotic resistance in tuberculosis and for developing novel treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1388658-04-5 |
| Applications | EthR Inhibitor |
| Formula | C22H18N2O3S |
| Molecular Weight | 390.45 |
| SMILES | O=C(NC1=CC=C(C2=NC3=CC=CC=C3S2)C=C1)COC4=CC=CC(OC)=C4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.